Perrigo | PRGO - Operating Expenses


Perrigo reported $1.03B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Abbott USD 9.31B 104M Mar/2026
Bayer EUR 10.33B 126M Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Coherus Biosciences USD 51.83M 2.48M Dec/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Merck USD 10.16B 558M Dec/2025
Nestle CHF 38.42B 1.33B Dec/2025
Pacira USD 193.68M 27.32M Dec/2025
Perrigo USD 1.03B 75.3M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 200.95M 6.51M Dec/2025
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
Sanofi EUR 9.31B 1.2B Mar/2026
Supernus Pharmaceuticals USD 197.75M 54.54M Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025